Menopause Hormone Therapy (HRT) in McKinney, TX

Bioidentical hormones in McKinney: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Texas decides what, if anything, fits, and the form. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

At 17.3 OB-GYNs per 100,000 residents (35 listed in the NPI registry), McKinney sits near the national 17.8 and above Texas's 15.4; 44% of the cities VevaMD covers have a lower rate. Set against the city's 24,766 women aged 45 to 64, that is one OB-GYN for roughly every 710.

Widen the circle and the count grows: 70 in the city or within 10 miles, 456 within 25 miles. For the 2,645,035 people who live within 25 miles, that is 17.2 per 100,000. VevaMD is an online option alongside them: a physician licensed in Texas reviews your intake from McKinney without an office visit, and an OB-GYN you already see stays your doctor.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11